Drawing for LIDIA

USPTO serial 98814302

LIDIA

Reviewed by CopyMark Law Group

Status 641Office Action
Filing date
Status date
Registration date
—
Examiner
CORDANI, CAITLIN A
Law office
TMEG LAW OFFICE 109

What this means

The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.

Status 641: Status 641 means the USPTO mailed a non-final Office Action identifying issues with your application. You typically have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.

Need help with LIDIA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Office Action, set up monitoring, or talk with CopyMark.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Rebecca Liebowitz

Rebecca Liebowitz Venable LLPP.O. Box 34385Washington, DC 20043-9998United States

Goods and services

ClassDescriptionStatusFirst use
009Scientific apparatus and instruments, namely, apparatus for conducting genomic analysis; scientific research and laboratory apparatus, namely, apparatus for conducting genomic analysis; scientific laboratory research apparatus for conducting polymerase chain reaction (PCR) analysis; scientific laboratory apparatus for DNA and RNA amplification and sequencing for research purposes; scientific laboratory research apparatus for semiconductor sequencing; scientific laboratory research apparatus for on-chip DNA and RNA amplification sequencing and measurement; silicon transistors; microchips; data processing equipment; recorded computer software for genomic analysis; recorded bioinformatics software; recorded software for microbial pathogen detection and identification; recorded computer software for the diagnosis of sepsis and other medical conditions; scientific apparatus, namely, semiconductors and microchips for sequencing and measurement of DNA and RNA for scientific medical research and veterinary purposesACTIVE—
010Medical and veterinary apparatus and instruments for use in molecular diagnostics; medical apparatus for providing diagnostic sequencing of blood samples, DNA and RNA; medical apparatus for microbial pathogen detection and identification; medical apparatus for the diagnosis and monitoring of sepsis; medical apparatus for DNA and RNA testing for medical purposes; medical apparatus for the diagnosis and monitoring of cancer; medical apparatus for testing blood samples, cancer cells, DNA,RNA and protein; apparatus for PCR analysis and DNA and RNA sequencing for medical and veterinary purposes; medical diagnostic apparatus for taking and storing blood samples; vials and other containers in the nature of tubes for blood and other medical sample collectionACTIVE—
042Scientific and technological services, namely, scientific research, analysis and testing in the field of genomic analysis; scientific research laboratory services in the testing, sequencing and measurement of DNA and RNA; medical research laboratory services; scientific laboratory analysis; electronic data storage services; scientific and technological consultancy and advisory services relating to the aforesaid servicesACTIVE—
044Medical and veterinary services; healthcare services; DNA and RNA screening for medical purposes; genetic and blood testing, sequencing and measuring services for medical diagnostic purposes; provision of information relating to the analysis of DNA and RNA for medical diagnostic purposes; genetic testing for medical purposes; medical diagnostic testing, monitoring and reporting services; medical and veterinary consultancy and advisory services relating to the aforesaid servicesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (GNRN): A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.

DateCodeEventWhat it means
Aug 11, 2026GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 11, 2026GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 11, 2026CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 6, 2026GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Aug 6, 2026XAECEXAMINER'S AMENDMENT ENTERED—
Aug 6, 2026GNEAEXAMINERS AMENDMENT E-MAILED—
Aug 6, 2026CNEAEXAMINERS AMENDMENT -WRITTEN—
May 11, 2026GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
May 11, 2026GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
May 11, 2026CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
May 1, 2026RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION—
Aug 25, 2025GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Aug 25, 2025GNSLLETTER OF SUSPENSION E-MAILED—
Aug 25, 2025CNSLSUSPENSION LETTER WRITTEN—
Jul 28, 2025TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jul 28, 2025CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jul 28, 2025TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 29, 2025GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 29, 2025GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 29, 2025CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 23, 2025DOCKASSIGNED TO EXAMINER—
Apr 22, 2025NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jan 24, 2025TAEATEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED—
Jan 24, 2025PARITEAS VOLUNTARY AMENDMENT RECEIVED—
Oct 22, 2024NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance